Despite bipartisan agreement on the need for testing and treatment for the life-threatening liver disease hepatitis C, potentially hundreds of thousands of Americans remain untreated or even unaware they’re infected as efforts to expand access to cures have stalled in Congress.
Legislation introduced last year has struggled to gain traction as lawmakers focus on other priorities and succumb to partisan divisions.
The result is that while countries like England are on track to eliminate hepatitis C as a public health threat within the next few years, the United States is falling well behind.
